Transcriptomic signatures of MSI-high metastatic colorectal cancer to predict efficacy of immune checkpoint inhibitors

被引：0
|
作者：
Gallois, Claire
Landi, Matteo
Taieb, Julien
Lonardi, Sara
Bergamo, Francesca
Intini, Rossana
Maddalena, Giulia
Pietrantonio, Filippo
Corti, Francesca
Ambrosini, Margherita
Martinetti, Antonia
Germani, Marco Maria
Boccaccio, Chiara
Vetere, Guglielmo
Mouillet-Richard, Sophie
de Reynies, Aurelien
Puig, Pierre Laurent
Cremolini, Chiara
机构：
[1] Univ Paris Cite, Inst Canc Paris CARPEM, Digest Oncol Dept, Hop Europeen G Pompiduo, Paris, France
[2] Univ Pisa, Pisa, Italy
[3] Univ Paris, Dept Gastroenterol & Gastrointestinal Oncol, Hop Europeen Georges Pompidou, AP HP, Paris, France
[4] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Padua, Italy
[5] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Med Oncol 1, Padua, Italy
[6] Veneto Inst Oncol IOV IRCCS, Dept Oncol, Med Oncol 1, Padua, Italy
[7] Ist Oncol Veneto IOV IRCCS, Oncol Unit 1, Padua, Italy
[8] Fdn IRCCS Ist Nazl Tumori, Med Oncol Dept, Milan, Italy
[9] IRCCS Fdn Natl Canc Inst, Milan, Italy
[10] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[11] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy
[12] Univ Paris Cite, Sorbonne Univ, Ctr Rech Cordeliers, INSERM, Paris, France
[13] Inst Canc Paris CARPEM, Dept Biol, Hop Europeen Georges Pompidou, APHP Ctr, Paris, France
[14] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy
[15] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3570
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Biomarkers to predict efficacy of immune checkpoint inhibitors in colorectal cancer patients: a systematic review and meta-analysis
    Yu, Hang
    Liu, Qingquan
    Wu, Keting
    Tang, Shuang
    CLINICAL AND EXPERIMENTAL MEDICINE, 2024, 24 (01)
  • [32] Stratification of risk based on immune signatures and prediction of the efficacy of immune checkpoint inhibitors in prostate cancer
    Sun, Yidan
    Yang, Xinyu
    Ren, Shiqi
    Lu, Zhichao
    Liu, Zongheng
    Kong, Fanming
    Wang, Ziheng
    Yang, Yang
    JOURNAL OF MENS HEALTH, 2023, 19 (11) : 16 - 33
  • [33] Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
    Loupakis, Fotios
    Maddalena, Giulia
    Depetris, Ilaria
    Murgioni, Sabina
    Bergamo, Francesca
    Dei Tos, Angelo Paolo
    Rugge, Massimo
    Munari, Giada
    Nguyen, Andrew
    Szeto, Christopher
    Zagonel, Vittorina
    Lonardi, Sara
    Fassan, Matteo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
  • [34] Biological properties associated with improved survival in MSI-high sporadic colorectal cancer
    Robinson, JM
    Bierner-Huettman, AE
    Purdie, DM
    Reid, LE
    Walsh, WD
    Simms, LA
    Young, J
    Leggett, B
    Leggett, A
    Jass, JR
    Radford-Smith, GL
    GASTROENTEROLOGY, 2001, 120 (05) : A664 - A664
  • [35] Real-world experience of immune checkpoint inhibitors in MSI-H/dMMR metastatic colorectal cancer in a tertiary cancer center in Saudi Arabia
    Ajina, R.
    Alhareeri, A.
    Philip, W.
    Alsekait, N.
    Alarifi, N.
    Alismail, H.
    Alshieban, S.
    Almuzzaini, B.
    Alshammari, K.
    ANNALS OF ONCOLOGY, 2023, 34 : S117 - S117
  • [36] Clinical biomarkers to predict the efficacy of immune checkpoint inhibitors
    Miura, Satoru
    ANNALS OF ONCOLOGY, 2021, 32 : S255 - S255
  • [37] Immune checkpoint inhibitors for metastatic bladder cancer
    Cubelli, Marta
    Di Nunno, Vincenzo
    Rihawi, Karim
    Massari, Francesco
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S720 - S732
  • [38] Immune checkpoint inhibitors for metastatic bladder cancer
    Massari, Francesco
    Di Nunno, Vincenzo
    Cubelli, Marta
    Santoni, Matteo
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Cheng, Liang
    Lopez-Beltran, Anto
    Battelli, Nicola
    Ardizzoni, Andrea
    CANCER TREATMENT REVIEWS, 2018, 64 : 11 - 20
  • [39] The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review
    Guven, Deniz Can
    Kavgaci, Gozde
    Erul, Enes
    Syed, Masood Pasha
    Magge, Tara
    Saeed, Anwaar
    Yalcin, Suayib
    Sahin, Ibrahim Halil
    ONCOLOGIST, 2024, : e580 - e600
  • [40] CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors
    Ziranu, Pina
    Pretta, Andrea
    Pozzari, Marta
    Maccioni, Antonio
    Badiali, Manuela
    Fanni, Daniela
    Lai, Eleonora
    Donisi, Clelia
    Persano, Mara
    Gerosa, Clara
    Puzzoni, Marco
    Bardanzellu, Fabio
    Ambu, Rossano
    Pusceddu, Valeria
    Dubois, Marco
    Cerrone, Giulia
    Migliari, Marco
    Murgia, Sara
    Spanu, Dario
    Pretta, Gianluca
    Aimola, Valentina
    Balconi, Francesca
    Murru, Stefania
    Faa, Gavino
    Scartozzi, Mario
    SCIENTIFIC REPORTS, 2023, 13 (01)
12345